Zobrazeno 1 - 10 of 56 pro vyhledávání: '"Andrés J M, Ferreri"'
2
Akademický článek
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
Autor: Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Ken H. Young
Publikováno v: Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
Abstract Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap clinically. Using machine learning, we developed an approach to s
Externí odkaz: https://doaj.org/article/93888a803eda4609ab485bda57596d9c
Zobrazit plný text záznamu
4
Akademický článek
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
Autor: Manman Deng, Mingzhi Zhang, Zijun Y. Xu-Monette, Lan V. Pham, Alexandar Tzankov, Carlo Visco, Xiaosheng Fang, Govind Bhagat, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, William W. L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick Hagemeister, Lapo Alinari, Yong Li, Michael Andreeff, Bing Xu, Ken H. Young
Publikováno v: Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2020)
Abstract The XPO1 inhibitor selinexor was recently approved in relapsed/refractory DLBCL patients but only demonstrated modest anti-DLBCL efficacy, prompting us to investigate the prognostic effect of XPO1 in DLBCL patients and the rational combinati
Externí odkaz: https://doaj.org/article/c7f6b942461b4f9b84f6332a99a2ce26
Zobrazit plný text záznamu
5
Akademický článek
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients
Autor: Michela Destito, Aldo Marzullo, Riccardo Leone, Paolo Zaffino, Sara Steffanoni, Federico Erbella, Francesco Calimeri, Nicoletta Anzalone, Elena De Momi, Andrés J. M. Ferreri, Teresa Calimeri, Maria Francesca Spadea
Publikováno v: Bioengineering, Vol 10, Iss 3, p 285 (2023)
Primary Central Nervous System Lymphoma (PCNSL) is an aggressive neoplasm with a poor prognosis. Although therapeutic progresses have significantly improved Overall Survival (OS), a number of patients do not respond to HD–MTX-based chemotherapy (15
Externí odkaz: https://doaj.org/article/d91feb0710cb4c53867fa2fa6967befb
Zobrazit plný text záznamu
6
Akademický článek
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
Autor: Zijun Y. Xu-Monette, Jianyong Li, Yi Xia, Beryl Crossley, Robert D. Bremel, Yi Miao, Min Xiao, Thomas Snyder, Ganiraju C. Manyam, Xiaohong Tan, Hongwei Zhang, Carlo Visco, Alexandar Tzankov, Karen Dybkaer, Govind Bhagat, Wayne Tam, Hua You, Eric D. Hsi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Miguel A. Piris, Jane N. Winter, Jeffrey T. Medeiros, Bing Xu, Yong Li, Ilan Kirsch, Ken H. Young
Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Background Diffuse large B-cell lymphoma (DLBCL) harbors somatic hypermutation (SHM) in the immunoglobulin heavy chain and light chain variable region genes, IGHV and IGK/LV. Recent studies have revealed that IGV SHM creates neoantigens that
Externí odkaz: https://doaj.org/article/4d22ed39e9c44774bc0de47c25ddda03
Zobrazit plný text záznamu
8
Autologous hematopoietic cell transplantation versus whole‐brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta‐analysis
Autor: Narendranath Epperla, Tea Reljic, Sayan Mullick Chowdhury, Andrés J. M. Ferreri, Ambuj Kumar, Mehdi Hamadani
Publikováno v: Hematological Oncology. 41:88-96
The management of newly diagnosed primary central nervous system lymphoma (PCNSL) includes administration of high-dose methotrexate based regimens followed by consolidation therapy to minimize the risk of relapse. However, the best consolidation stra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ec33edb2582eb335461454f7bad412
https://doi.org/10.1002/hon.3083
Zobrazit plný text záznamu
9
Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma
Autor: Ziyu She, Aldo Marzullo, Michela Destito, Maria Francesca Spadea, Riccardo Leone, Nicoletta Anzalone, Sara Steffanoni, Federico Erbella, Andrés J. M. Ferreri, Giancarlo Ferrigno, Teresa Calimeri, Elena De Momi
Publikováno v: International Journal of Computer Assisted Radiology and Surgery.
Purpose Primary central nervous system lymphoma (PCNSL) is a rare, aggressive form of extranodal non-Hodgkin lymphoma. To predict the overall survival (OS) in advance is of utmost importance as it has the potential to aid clinical decision-making. Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89a609c62ae24334562ca7020c117aa7
https://doi.org/10.1007/s11548-023-02886-2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje